
Peptides
Les peptides sont des chaînes courtes d'acides aminés liées par des liaisons peptidiques, jouant un rôle essentiel en tant que molécules biologiques dans divers processus cellulaires. Ils fonctionnent comme hormones, neurotransmetteurs et molécules de signalisation, et sont largement utilisés dans les applications thérapeutiques et diagnostiques. Les peptides sont également cruciaux dans la recherche pour étudier les interactions protéiques, les activités enzymatiques et les voies de signalisation cellulaire. Chez CymitQuimica, nous proposons une large sélection de peptides de haute qualité pour soutenir vos besoins en recherche et développement en biotechnologie et en pharmacie.
Sous-catégories appartenant à la catégorie "Peptides"
Produits appartenant à la catégorie "Peptides"
Trier par
SCRT2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SCRT2 antibody, catalog no. 70R-8980Degré de pureté :Min. 95%DL-Homoserine
CAS :Formule :C4H9NO3Degré de pureté :>98.0%(T)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :119.12[Asn1,Val5]-Angiotensin II
CAS :[Asn1,Val5]-Angiotensin II is a peptide that is used as a research tool to study the effects of angiotensin II on ion channels, ligand-receptor interactions and protein interactions. It is also used as an antibody to measure the level of angiotensin II in cells. This peptide has been shown to be an activator of potassium channels and inhibits calcium channels. The high purity of this product makes it suitable for use in pharmacology and cell biology research.Formule :C49H70N14O11Degré de pureté :Min. 95%Masse moléculaire :1,031.2 g/molFmoc-Asp(OtBu)-Wang Resin (100-200 mesh) 1% DVB
Fmoc-Asp(OtBu)-Wang resin is a 1% DVB resin that can be used as an inhibitor of peptide synthesis. It has been shown to selectively inhibit the binding of the L-type calcium channel, which is a cell membrane protein that affects the transport of calcium ions in and out of cells. Fmoc-Asp(OtBu)-Wang resin binds to the receptor site, preventing the natural ligand from binding. This inhibition prevents the activation of ion channels and reduces calcium ion influx into cells, leading to an anti-inflammatory effect.Degré de pureté :Min. 95%GPLGIAGQ TFA(109053-09-0 free base)
GPLGIAGQ TFA is an MMP2-responsive polypeptide linker for targeted tumor therapy in liposome/micelle nanocarriers.Formule :C33H54F3N9O12Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :825.83Pepstatin
CAS :Pepstatin (Pepsin Inhibitor S 735A) is a specific and orally aspartate protease inhibitor that also inhibits HIV protease activity. Cost effective and quality assured.Formule :C34H63N5O9Degré de pureté :96.74% - 99.94%Couleur et forme :SolidMasse moléculaire :685.89N-(2-PYRIDYLMETHYL)GLYCINE ETHYL ESTER
CAS :Formule :C10H14N2O2Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :194.2304Ac-LSHVLYSIAFED-NH2
Peptide Ac-LSHVLYSIAFED-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-LSHVLYSIAFED-NH2 include the following: Defining the CD59-C9 binding interaction Y Huang, F Qiao, R Abagyan , S Hazard - Journal of Biological , 2006 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)34916-6/abstractH-LTFPTGR^-OH
Peptide H-LTFPTGR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LTFPTGR^-OH include the following: Targeted host cell protein quantification by LC-MRM enables biologics processing and product characterization X Gao, B Rawal , Y Wang, X Li , D Wylie, YH Liu - Analytical , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.9b03952H-SGEATDGARPQALPEPMQESK-OH
Peptide H-SGEATDGARPQALPEPMQESK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SGEATDGARPQALPEPMQESK-OH include the following: Cell-specific processing of chromogranin A in endocrine cells of the rat stomach P Norlen, WJ Curry, M Björkqvist - of Histochemistry & , 2001 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/002215540104900102 Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease G Sathe , M Albert, J Darrow , A Saito - Journal of , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/jnc.15116TRAP-14 amide
CAS :Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormule :C81H119N21O22Masse moléculaire :1,738.96 g/molLCBiot-VPWMEPAYQRFL-OH
Peptide LCBiot-VPWMEPAYQRFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-VPWMEPAYQRFL-OH include the following: Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer YJ Kim, HI Lee, JK Kim, CH Kim , YJ Kim - Colloids and Surfaces B , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S092777652030059X Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy W Mohammed-Saeid, R Soudy, R Tikoo, K Kaur - 2018 - digitalcommons.chapman.eduhttps://digitalcommons.chapman.edu/pharmacy_articles/607/ Design and evaluation of gemini surfactant-based lipoplexes modified with cell-binding peptide for targeted gene therapy in melanoma model W Mohammed-Saeid , R Soudy - of Pharmacy & , 2018 - journals.library.ualberta.cahttps://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30010 Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets V Tolmachev , A Orlova - Current medicinal chemistry, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000024/art00004 Characterization and development of a peptide (p160) with affinity for neuroblastoma cells V Askoxylakis , W Mier , S Zitzmann - Journal of Nuclear , 2006 - Soc Nuclear Medhttps://jnm.snmjournals.org/content/47/6/981.short Preclinical evaluation of the breast cancer cell-binding peptide, p160 V Askoxylakis , S Zitzmann, W Mier , K Graham - Clinical cancer , 2005 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/11/18/6705/185959 Characterisation and in vitro and in vivo evaluation of a breast cancer cell-and neuroblastoma cell binding peptide (p160), identified through phage display V Askoxylakis - 2007 - archiv.ub.uni-heidelberg.dehttps://archiv.ub.uni-heidelberg.de/volltextserver/7625/1/ve_Sep13_141530.pdf Design, synthesis, and validation of an in vitro platform peptide-whole cell screening assay using MTT reagent S Ahmed, K Kaur - Journal of Taibah University for Science, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1658365516300802 Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer R Soudy, H Etayash , K Bahadorani - Molecular , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00652 Peptides targeting HER2-positive breast cancer cells and applications in tumor imaging and delivery of chemotherapeutics PA Cavallaro, M De Santo, EL Belsito, C Longobucco - Nanomaterials, 2023 - mdpi.comhttps://www.mdpi.com/2079-4991/13/17/2476 Therapeutic cancer targeting peptides OH Aina, TC Sroka, ML Chen - Peptide Science: Original , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.10257 Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel M Shahin, S Ahmed, K Kaur , A Lavasanifar - Biomaterials, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211003590 Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin M Shahin, R Soudy, H El-Sikhry, JM Seubert , K Kaur - Cancer letters, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304383512005952 Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer M Azari, F Bahreini , VN Uversky , N Rezaei - Biochemical Pharmacology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295223000503 Combinatorial discovery of tumor targeting peptides using phage display LA Landon, SL Deutscher - Journal of cellular biochemistry, 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.10634 Development of Novel Peptide-Doxorubicin Conjugates for Targeting Triple-Negative Breast Cancer A Saghaeidehkordi - 2021 - search.proquest.comhttps://search.proquest.com/openview/0a7f923b82b25109d646e28de819bb53/1?pq-origsite=gscholar&cbl=18750&diss=yZNF793 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF793 antibody, catalog no. 70R-8884Degré de pureté :Min. 95%F2RL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of F2RL2 antibody, catalog no. 70R-9968Degré de pureté :Min. 95%Prolactin Releasing Peptide (1-31), bovine
Catalogue peptide; min. 95% purityFormule :C157H244N54O41SMasse moléculaire :3,576.01 g/molRCAN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RCAN2 antibody, catalog no. 70R-9145Degré de pureté :Min. 95%H-P^GLYYF-OH
Peptide H-P^GLYYF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-P^GLYYF-OH include the following: Establishment of anti-C1q monoclonal antibodies to measure serum C1q levels discriminating disease severity subsets of rheumatoid arthritis within 5 years of onset C Yukioka, K Ebina, Y Shimaoka - Modern , 2020 - academic.oup.comhttps://academic.oup.com/mr/article-abstract/30/5/816/6301559QWF
CAS :Tripeptide SP antagonist (IC50: 90 μM); blocks SP-MRGPR X2 binding and mast cell degranulation; reduces 48/80-induced scratching in mice.Formule :C38H43N5O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :697.78GsMTx4
CAS :Selective blocker of mechanosensitive ion channelsFormule :C185H273N49O45S6Degré de pureté :Min. 95%Masse moléculaire :4,101.89 g/molPCDH1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PCDH1 antibody, catalog no. 70R-6115Degré de pureté :Min. 95%